Endpoint Eclinical India Private Limited - Due diligence report

A 360° intelligence report on Endpoint Clinical: trust score, financial health, credit view, compliance, directors, growth and distress sign…

2017-12-12 Hyderabad, Telangana Active Unlisted Active Compliant
Share
EE Endpoint Eclinical India Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Endpoint Clinical — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Endpoint Clinical is assessed as Low Risk with a Trust Score of 88/100. Endpoint Clinical is an active private limited foreign company incorporated in india incorporated in 2017, operating in the Information Technology sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Endpoint Eclinical India Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
90/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 90/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
SANDEEP THALLA 01234567 Director 01/04/2018 6 yrs Approved
MOHIT AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
ARAVIND RAMACHANDRAN 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Labcorp Endpoint Clinical Inc (formerly: Endpoint Clinical Inc)
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Labcorp Endpoint Clinical Inc (formerly: Endpoint Clinical Inc) Holding Company 74.00%

Key managerial personnel: ARAVIND RAMACHANDRAN (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
EPFO headcount growing - hiring signal.
Operating for 8 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 6 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
29 Sep 2025
Director ceased
ARAVIND RAMACHANDRAN
22 Mar 2025
Director appointed
ARAVIND RAMACHANDRAN (Whole-time director)
27 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
25 Sep 2023
Director ceased
DAVID HOWARD COOPER
30 Sep 2020
Director ceased
SANDEEP THALLA
Director ceased
MOHIT AGARWAL
25 Aug 2020
Director appointed
SANDEEP THALLA (Director)
18 Aug 2020
Director ceased
PRASANNA MANJUNATH BHAT
20 Jan 2020
Director ceased
SUMA VALLOLI RADHAKRISHNA
Director ceased
MALINI RAJU
27 Dec 2019
Director appointed
MOHIT AGARWAL (Director)
18 Sep 2019
Director ceased
CHARLES DAVID HARRIS
06 May 2019
Director ceased
DANIEL CLIFFORD ROGERS
21 Dec 2018
Director ceased
SMITA RAJEEV PANDIT
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dupro Consultants Private Limited U93000TN2008PTC070220 Chennai, Tamil Nadu, India
Jayam Solutions U72900TG2002PTC038849 Hyderabad, Telangana, India
Humanetics Innovative Solutions India Private Limited U74900KA2015FTC084379 Bangalore North, Karnataka, India
Sns Tech U72100MH2000PTC124860 Mumbai, Maharashtra, India
Mindarray Systems U72200GJ2010PLC062256 Daskroi, Gujarat, India
Neev Systems Private Limited U72900TG2016PTC113120 Hyderabad, Telangana, India
Altium Limited U72501KA2019FTC127213 Bangalore North, Karnataka, India
Visual Bi Solutions (India) Private Limited U72200TN2011PTC080562 Chinglepet, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Endpoint Clinical before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Endpoint Clinical: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 90/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Endpoint Clinical - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Endpoint Clinical pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Endpoint Clinical - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Endpoint Clinical an active company?

Endpoint Clinical has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Endpoint Clinical financially healthy?

Endpoint Clinical has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Endpoint Clinical?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Endpoint Clinical?

The ultimate holding entity is Labcorp Endpoint Clinical Inc (formerly: Endpoint Clinical Inc). 3 active director(s) are on record.

Does Endpoint Clinical have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Endpoint Clinical up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Endpoint Clinical?

Its Credit Risk Score is 90/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.